Michael P Kim
Overview
Explore the profile of Michael P Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomita K, Maxwell J, Snyder R, Kim M, Tran Cao H, Tzeng C, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40045147
Central pancreatectomy (CP) is one of the parenchyma-sparing approaches proposed for low-grade tumors. CP has a lower incidence of diabetes compared with distal pancreatectomy, but may harbor risks of positive...
2.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F, et al.
Nature
. 2025 Mar;
PMID: 40044861
Mesenchymal plasticity has been extensively described in advanced epithelial cancers; however, its functional role in malignant progression is controversial. The function of epithelial-to-mesenchymal transition (EMT) and cell plasticity in tumour...
3.
Torres M, Maxwell J, Snyder R, Tran Cao H, Kim M, Tzeng C, et al.
Ann Surg Oncol
. 2024 Sep;
31(13):8721-8722.
PMID: 39284994
Background: Robotic pancreatoduodenectomy is an increasingly accepted alternative for the treatment of pancreatic ductal adenocarcinoma (PDAC). However, the ability to perform a meticulous robotic-assisted superior mesenteric artery (SMA) dissection to...
4.
Habib J, Kinny-Koster B, Javed A, Zelga P, Saadat L, Kim R, et al.
J Clin Oncol
. 2024 Sep;
42(36):4317-4326.
PMID: 39255450
Purpose: The benefit of adjuvant therapy for intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) remains unclear because of severely limited evidence. Although biologically distinct entities, adjuvant therapy practices...
5.
Lu P, Lyu H, Prakash L, Chiang Y, Maxwell J, Snyder R, et al.
Surg Endosc
. 2024 Jul;
38(9):4986-4995.
PMID: 38987482
Background: Although robotic pancreatectomy may facilitate an earlier functional recovery, the impact of a robotic pancreatectomy program during its early experience on the timing of return to intended oncologic therapy...
6.
Dilly J, Hoffman M, Abbassi L, Li Z, Paradiso F, Parent B, et al.
Cancer Discov
. 2024 Jul;
14(11):2135-2161.
PMID: 38975874
KRAS inhibitors demonstrate clinical efficacy in pancreatic ductal adenocarcinoma (PDAC); however, resistance is common. Among patients with KRASG12C-mutant PDAC treated with adagrasib or sotorasib, mutations in PIK3CA and KRAS, and...
7.
Baydogan S, Mohindroo C, Hasanov M, Montiel M, Quesada P, Cazacu I, et al.
Endosc Ultrasound
. 2024 Jul;
13(2):83-88.
PMID: 38947744
Background And Objectives: Pancreatic cancer (PC) is the third cause of cancer-related deaths. Early detection and interception of premalignant pancreatic lesions represent a promising strategy to improve outcomes. We evaluated...
8.
Shi C, De B, Tran Cao H, Liu S, Florez M, Kouzy R, et al.
Cancer Med
. 2024 Jun;
13(12):e7434.
PMID: 38923407
Introduction: With locally advanced pancreatic cancer (LAPC), uncontrolled local tumor growth frequently leads to mortality. Advancements in radiotherapy (RT) techniques have enabled conformal delivery of escalated-dose RT (EDR), which may...
9.
Tan X, Wang S, Xiao G, Wu C, Liu X, Zhou B, et al.
J Clin Invest
. 2024 Apr;
134(12).
PMID: 38662435
Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identified a chromosome 3q amplicon that serves as a platform for secretory regulation in cancer. The 3q amplicon...
10.
Mohindroo C, Baydogan S, Agarwal P, Wright R, Prakash L, Mork M, et al.
Cancer Prev Res (Phila)
. 2024 Apr;
17(7):335-342.
PMID: 38662083
Ten percent of pancreatic neuroendocrine tumors (pNET) are related to inherited syndromes (MEN1, MEN4, VHL, NF1, and TSC). Growing evidence suggests that clinically sporadic pNETs can also harbor germline pathogenic...